Skip to main content

JPML Denies To Vacate Conditional Transfer of Taxotere Cases

JPML Denies To Vacate Conditional Transfer of Taxotere Cases

JPML Denies To Vacate Conditional Transfer of Taxotere Cases

Introduction

The request to vacate the conditional transfer of one Taxotere lawsuit was denied by the JPML panel on the grounds that the transfer would further expedite the litigation process as a whole. The case was initially filed in Delaware state court then moved to the U.S. District Court, District of Delaware, before being conditionally transferred to the MDL in Louisiana. From January 28, 2019, the Taxotere Bellwether trials will begin for cases filed under MDL: 2740 set up for the purpose of coordinated pretrial proceedings of Taxotere hair loss litigations. The order was signed by Judge Kurt D. Engelhardt. This centralization is witnessing a steady rise in the filing of Taxotere hair loss lawsuits, in the U.S. District Court, Eastern District of Louisiana, with the number nearing 1500 in the month of August. Additional bellwether trials are planned for April 8, July 15, and November 4, of 2019.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!